Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Generic Velpatasvir Plus Sofosbuvir With or Without Ribavirin for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus

NCT03250910 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03250910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03250910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Generic Velpatasvir Plus Sofosbuvir With or Without Ribavirin for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2016
Completion date
October 31, 2017
Enrollment
228 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus infection, response to therapy of, human immunodeficiency virus